Publications by authors named "Athanasios Zomas"

Claim this Profile
R
Real-world outcomes of brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in relapsed/refractory Hodgkin lymphoma: A systematic review and meta-analysis.
Anna Sureda, Astrid Pavlovsky, Dalah Haidar, Fjoralba Kristo, Vanessa Stache, Athanasios Zomas

Bone Marrow Transplant· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial.
Peter Borchmann, Justin Ferdinandus, Gundolf Schneider, Alden Moccia, Richard Greil, Athanasios Zomas

Lancet· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Chart Review of Treatment Patterns and Overall Survival among a Cohort of Patients with Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom.
Chalid Assaf, Timothy M Illidge, Nathalie Waser, Mary He, Tina Li, Athanasios Zomas

Cancers (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line treatment of stage IIB to stage IV classical Hodgkin lymphoma in Italy, Israel, and Spain: Patient characteristics, treatment patterns, and clinical outcomes.
Abraham Avigdor, Fabrizio Trinchese, Francois Gavini, Nawal Bent-Ennakhil, Mehul Dalal, Athanasios Zomas

EJHaem· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of brentuximab vedotin monotherapy in relapsed or refractory Hodgkin lymphoma: a systematic review and meta-analysis.
Wouter J Plattel, Aurore Bergamasco, Fabrizio Trinchese, François Gavini, Nawal Bent-Ennakhil, Athanasios Zomas

Leuk Lymphoma· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries.
Chalid Assaf, Nathalie Waser, Martine Bagot, Mary He, Tina Li, Athanasios Zomas

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of front-line treatments for advanced Hodgkin lymphoma: a systematic literature review.
Mehul Dalal, Jatin Gupta, Kim Price, Athanasios Zomas, Harry Miao

Expert Rev Hematol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma.
Evangelos Terpos, Karthik Ramasamy, Nadjoua Maouche, Jiri Minarik, Ioannis Ntanasis-Stathopoulos, Athanasios Zomas

Ann Hematol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation.
Panayotis Kaloyannidis, Mark Hertzberg, Kate Webb, Athanasios Zomas, Rudolf Schrover

Br J Haematol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies.
Flora Zagouri, Efstathios Kastritis, Athanasios Zomas, Evangelos Terpos, Eirini Katodritou

Eur J Haematol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma.
Efstathios Kastritis, Evangelos Terpos, Maria Roussou, Maria Gavriatopoulou, Magdalini Migkou, Athanasios Zomas

Haematologica· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of life-threatening autoimmune haemolytic anaemia with ofatumumab in a patient with systemic lupus erythematosus.
Theofanis Karageorgas, Athanasios Zomas, Pinelopi Kazakou, Pelagia Katsimbri, Marina Mantzourani

Rheumatology (Oxford)· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct evidence for normalization of platelet function resulting from platelet count reduction in essential thrombocythemia.
Argirios E Tsantes, Georgios K Nikolopoulos, Panagiotis Tsirigotis, Katerina Zoi, Athanasios Zomas

Blood Coagul Fibrinolysis· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years.
Efstathios Kastritis, Marie-Christine Kyrtsonis, Evdoxia Hatjiharissi, Argiris Symeonidis, Eurydiki Michalis, Athanasios Zomas

Am J Hematol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostication of the high-risk WM patient.
Efstathios Kastritis, Maria Gavriatopoulou, Marie-Christine Kyrtsonis, Michael Michael, Evdoxia Hadjiharissi, Athanasios Zomas

Clin Lymphoma Myeloma Leuk· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH).
Efstathios Kastritis, Marie-Christine Kyrtsonis, Evdoxia Hadjiharissi, Argyris Symeonidis, Evridiki Michalis, Athanasios Zomas

Leuk Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents.
Evangelos Terpos, Eirini Katodritou, Maria Roussou, Anastasia Pouli, Eurydiki Michalis, Athanasios Zomas

Eur J Haematol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostication in young and old patients with Waldenström's macroglobulinemia: importance of the International Prognostic Scoring System and of serum lactate dehydrogenase.
Efstathios Kastritis, Konstantinos Zervas, Panagiotis Repoussis, Evridiki Michali, Eirini Katodrytou, Athanasios Zomas

Clin Lymphoma Myeloma· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The International Prognostic Scoring System for Waldenstrom's macroglobulinemia is applicable in patients treated with rituximab-based regimens.
Meletios Athanasios Dimopoulos, Efstathios Kastritis, Sossana Delimpassi, Athanasios Zomas, Marie Christine Kyrtsonis

Haematologica· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scintigraphy with technetium-99m methoxyisobutylisonitrile in multiple myeloma patients: correlation with the International Staging System.
John Koutsikos, Vasiliki Grigoraki, Theodoros Athanasoulis, Antigoni Velidaki, Charalampos Mamoulakis, Athanasios Zomas

Hell J Nucl Med· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of serum beta2-microglobulin in patients with Waldenstrom's macroglobulinemia requiring treatment.
Athanasios Anagnostopoulos, Konstantinos Zervas, Marie Kyrtsonis, Argyris Symeonidis, Dimitra Gika, Athanasios Zomas

Clin Lymphoma Myeloma· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary treatment with pulsed melphalan, dexamethasone and thalidomide for elderly symptomatic patients with multiple myeloma.
Meletios A Dimopoulos, Athanasios Anagnostopoulos, Evangelos Terpos, Panagiotis Repoussis, Athanasios Zomas

Haematologica· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors for response to rituximab in Waldenstrom's macroglobulinemia.
Meletios A Dimopoulos, Athanasios Anagnostopoulos, Constantinos Zervas, Marie C Kyrtsonis, Athanasios Zomas

Clin Lymphoma· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of relapsed/refractory multiple myeloma with thalidomide-based regimens: identification of prognostic factors.
Athanasios Anagnostopoulos, Dimitra Gika, George Hamilos, Konstantinos Zervas, Athanasios Zomas

Leuk Lymphoma· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive therapy for aggressive lymphoma.
Athanasios Zomas, Anastasia Skandalis

N Engl J Med· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis